Altay BiopharmaArticle (-218 characters)
Altay Biopharma is a biotechnology company developing therapies aimed at increasing the lifespan of people living with fibrotic diseases that is headquartered in San Bruno, California and was founded in 2017.
Products
Altay Biopharma
Altay Biopharma is a biotechnology company founded in 2017 and based in San Bruno, California focused on developing life-extending treatments for fibrotic diseases, such as lung fibrosis and liver fibrosis.
Article (-161 characters)
ALT-CP1
Altay’s lead compound ALT-CP1 targets inflammation and has been demonstrated pre-clinical efficacy for treating lung and liver fibrosis in mouse models.
Table (-2 rows) (-4 cells) (-37 characters)